Roche bags 'break­through' an­ti-fi­bro­sis drug in $1.4B biotech buy­out deal

Roche is snap­ping up a “break­through” an­ti-fi­brot­ic drug in a $1.4 bil­lion buy­out.

The phar­ma gi­ant an­nounced Fri­day that it is ac­quir­ing Prome­dior, pri­mar­i­ly to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.